ERC’s products include in-line membrane vacuum degassing solutions, refractive index detectors and ozone generation systems.
Based in Kawaguchi, Japan, ERC has a global customer base and annual revenues of approximately ¥2.14 billion. ERC will operate within the IDEX Health and Science Technologies segment.
Commenting on the acquisition, IDEX chairman and CEO Andrew Silvernail said: “ERC provides IDEX with access to key analytical instrumentation customers, a strong manufacturing base in Japan, vital products for clinical diagnostic applications and a gateway to the burgeoning instrumentation markets of Asia.”
ERC president Yoshio Ishii added: “We believe the chance to join IDEX’s Health and Science Technologies segment and their global family of brands is a great opportunity for our customers, suppliers and employees. IDEX’s commitment to the instrumentation market is well established, and we look forward to working together to achieve continued growth and success in this marketplace.”
